Your browser doesn't support javascript.
loading
A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022.
Vaughan, Aisling M; Cenciarelli, Orlando; Colombe, Soledad; Alves de Sousa, Luís; Fischer, Natalie; Gossner, Celine M; Pires, Jeff; Scardina, Giuditta; Aspelund, Gudrun; Avercenko, Margarita; Bengtsson, Sara; Blomquist, Paula; Caraglia, Anna; Chazelle, Emilie; Cohen, Orna; Diaz, Asuncion; Dillon, Christina; Dontsenko, Irina; Kotkavaara, Katja; Fafangel, Mario; Ferraro, Federica; Firth, Richard; Fonager, Jannik; Frank, Christina; Carrasco, Mireia G; Gkolfinopoulou, Kassiani; Grenersen, Marte Petrikke; Guzmán Herrador, Bernardo R; Henczkó, Judit; Hoornenborg, Elske; Igoe, Derval; Ilic, Maja; Jansen, Klaus; Janța, Denisa-Georgiana; Johansen, Tone Bjordal; Kasradze, Ana; Koch, Anders; Kyncl, Jan; Martins, João Vieira; McAuley, Andrew; Mellou, Kassiani; Molnár, Zsuzsanna; Mor, Zohar; Mossong, Joël; Novacek, Alina; Orlikova, Hana; Pem Novosel, Iva; Rossi, Maria K; Sadkowska-Todys, Malgorzata; Sawyer, Clare.
Afiliação
  • Vaughan AM; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Cenciarelli O; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Colombe S; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Alves de Sousa L; Global Outbreak Alert and Response Network (GOARN), Geneva, Switzerland.
  • Fischer N; Outbreak Research Team, Institute of Tropical Medicine, Antwerp, Belgium.
  • Gossner CM; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Pires J; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Scardina G; Global Outbreak Alert and Response Network (GOARN), Geneva, Switzerland.
  • Aspelund G; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Avercenko M; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Bengtsson S; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Blomquist P; Centre for Health Security and Communicable Disease Control, The Directorate of Health, Reykjavik, Iceland.
  • Caraglia A; Infectious Disease Prevention and Control Unit, Department of Infectious Risks Analysis and Prevention, Centre for Disease Prevention and Control of Latvia, Riga, Latvia.
  • Chazelle E; Unit for Diagnostics Preparedness of Notifiable and High Consequence Pathogens, Public Health Agency of Sweden, Solna, Sweden.
  • Cohen O; Field Services, United Kingdom Health Security Agency, London, United Kingdom.
  • Diaz A; Directorate General of Health Prevention, Ministry of Health, Rome, Italy.
  • Dillon C; Santé publique France, the French National Public Health Agency, Saint-Maurice, France.
  • Dontsenko I; Division of Epidemiology, Public Health Services, Ministry of Health, Jerusalem, Israel.
  • Kotkavaara K; National Centre of Epidemiology, Carlos III Health Institute, CIBER in Infectious Diseases (CIBERINFEC), Madrid, Spain.
  • Fafangel M; Health Services Executive, Health Protection Surveillance Centre, Dublin, Ireland.
  • Ferraro F; Department of Communicable Diseases, Health Board, Tallinn, Estonia.
  • Firth R; Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Fonager J; Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
  • Frank C; Directorate General of Health Prevention, Ministry of Health, Rome, Italy.
  • Carrasco MG; Public Health Wales, Cardiff, United Kingdom.
  • Gkolfinopoulou K; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Grenersen MP; Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Guzmán Herrador BR; Ministry of Health, Government of Andorra, Andorra la Vella, Andorra.
  • Henczkó J; Surveillance Coordination Department. Hellenic National Public Health Organization (EODY), Athens, Greece.
  • Hoornenborg E; The Norwegian Institute of Public Health, Oslo, Norway.
  • Igoe D; Coordinating Centre for Health Alerts and Emergencies (CCAES), Directorate General of Public Health, Ministry of Health, Madrid, Spain.
  • Ilic M; Department of Microbiological Reference Laboratory, National Public Health Center, Budapest, Hungary.
  • Jansen K; Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, the Netherlands.
  • Janța DG; Health Services Executive, Health Protection Surveillance Centre, Dublin, Ireland.
  • Johansen TB; Croatian Institute of Public Health, Zagreb, Croatia.
  • Kasradze A; Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Koch A; National Centre of Surveillance and Control of Communicable Disease, National Institute of Public Health Romania, Bucharest, Romania.
  • Kyncl J; The Norwegian Institute of Public Health, Oslo, Norway.
  • Martins JV; Head of Public Health Emergency Preparedness and Response Division, National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • McAuley A; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Mellou K; Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic.
  • Molnár Z; Directorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal.
  • Mor Z; Public Health Scotland, Edinburgh, Scotland, United Kingdom.
  • Mossong J; Directorate of Epidemiological Surveillance and Intervention for Infectious Diseases, Hellenic National Public Health Organization (EODY), Athens, Greece.
  • Novacek A; Department of Communicable Disease Epidemiology and Infection Control, National Public Health Center, Budapest, Hungary.
  • Orlikova H; Public Health Services, Ministry of Health, Jerusalem, Israel.
  • Pem Novosel I; School of Health Sciences, Ashkelon Academic College, Ashkelon, Israel.
  • Rossi MK; Health Directorate, Luxembourg, Luxembourg.
  • Sadkowska-Todys M; Austrian Agency for Health and Food Safety (AGES), Vienna, Austria.
  • Sawyer C; Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic.
Euro Surveill ; 27(36)2022 09.
Article em En | MEDLINE | ID: mdl-36082686
ABSTRACT
Following the report of a non-travel-associated cluster of monkeypox cases by the United Kingdom in May 2022, 41 countries across the WHO European Region have reported 21,098 cases and two deaths by 23 August 2022. Nowcasting suggests a plateauing in case notifications. Most cases (97%) are MSM, with atypical rash-illness presentation. Spread is mainly through close contact during sexual activities. Few cases are reported among women and children. Targeted interventions of at-risk groups are needed to stop further transmission.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mpox / Exantema Tipo de estudo: Diagnostic_studies Limite: Animals / Child / Female / Humans Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mpox / Exantema Tipo de estudo: Diagnostic_studies Limite: Animals / Child / Female / Humans Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Dinamarca